Medically reviewed by Qin Rao, MD Gastrointestinal (GI) bleeding is a symptom of a disease, condition, or injury affecting ...
A new study highlights that the experimental blood-thinner abelacimab significantly reduces bleeding risks in atrial fibrillation patients compared to standard treatments like rivaroxaban. In trial ...
Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, ...
Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...